Therapeutic effect of aromatase inhibitor in two azoospermic dogs with high plasma estradiol-17beta levels

J Vet Med Sci. 2003 Dec;65(12):1343-5. doi: 10.1292/jvms.65.1343.

Abstract

Two azoospermic dogs with high plasma estradiol-17 beta (E(2)) levels were subcutaneously injected with an aromatase inhibitor (AI), 4-androstene-4-ol-3,17-dione, 2 mg every other day for 4 weeks. Before the AI treatment the plasma E(2) levels of the two dogs (21 and 22 pg/ml, respectively) were higher than those of 2 normal dogs (8.1 and 12.3 pg/ml), and they fell to 11-17 pg/ml between 1 and 4 weeks after the start of AI treatment. The plasma testosterone levels after the start of AI treatment had increased to 2.1-3.1 ng/ml. A small number of sperm were detected in the semen of the two dogs between 3 and 6 weeks after the start of AI treatment. These results indicate that the testicular function of infertile dogs with high plasma E(2) levels can be temporarily improved by AI therapy.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Aromatase Inhibitors*
  • Chorionic Gonadotropin / therapeutic use*
  • Dog Diseases / blood
  • Dog Diseases / drug therapy*
  • Dogs
  • Enzyme Inhibitors / therapeutic use*
  • Estradiol / blood*
  • Injections, Intramuscular
  • Male
  • Oligospermia / blood
  • Oligospermia / drug therapy
  • Oligospermia / veterinary*
  • Sperm Motility / drug effects
  • Spermatozoa / abnormalities
  • Testosterone / blood

Substances

  • Aromatase Inhibitors
  • Chorionic Gonadotropin
  • Enzyme Inhibitors
  • Testosterone
  • Estradiol